These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1531298)

  • 1. A conformational transition involved in antagonistic substrate binding to the allosteric phosphofructokinase from Escherichia coli.
    Deville-Bonne D; Garel JR
    Biochemistry; 1992 Feb; 31(6):1695-700. PubMed ID: 1531298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slow ligand-induced transitions in the allosteric phosphofructokinase from Escherichia coli.
    Auzat I; Gawlita E; Garel JR
    J Mol Biol; 1995 Jun; 249(2):478-92. PubMed ID: 7783204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate antagonism in the kinetic mechanism of E. coli phosphofructokinase-1.
    Deville-Bonne D; Laine R; Garel JR
    FEBS Lett; 1991 Sep; 290(1-2):173-6. PubMed ID: 1833241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steady-state fluorescence of Escherichia coli phosphofructokinase reveals a regulatory role for ATP.
    Berger SA; Evans PR
    Biochemistry; 1991 Aug; 30(34):8477-80. PubMed ID: 1832014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-induced conformational transitions in Escherichia coli phosphofructokinase 2: evidence for an allosteric site for MgATP2-.
    Guixé V; Rodríguez PH; Babul J
    Biochemistry; 1998 Sep; 37(38):13269-75. PubMed ID: 9748334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reaction path of phosphofructo-1-kinase is altered by mutagenesis and alternative substrates.
    Wang X; Kemp RG
    Biochemistry; 2001 Apr; 40(13):3938-42. PubMed ID: 11300773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH dependence of the kinetic properties of allosteric phosphofructokinase from Escherichia coli.
    Deville-Bonne D; Bourgain F; Garel JR
    Biochemistry; 1991 Jun; 30(23):5750-4. PubMed ID: 1828369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent binding of MgADP to the E187A mutant of Escherichia coli phosphofructokinase in the absence of allosteric effects.
    Pham AS; Janiak-Spens F; Reinhart GD
    Biochemistry; 2001 Apr; 40(13):4140-9. PubMed ID: 11300795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-steady state quantification of the allosteric influence of Escherichia coli phosphofructokinase.
    Pham AS; Reinhart GD
    J Biol Chem; 2001 Sep; 276(37):34388-95. PubMed ID: 11443117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active-site mutants altering the cooperativity of E. coli phosphofructokinase.
    Berger SA; Evans PR
    Nature; 1990 Feb; 343(6258):575-6. PubMed ID: 2137204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cooperativity and allosteric inhibition of Escherichia coli phosphofructokinase depend on the interaction between threonine-125 and ATP.
    Auzat I; Le Bras G; Garel JR
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5242-6. PubMed ID: 8202475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MgATP-dependent activation by phosphoenolpyruvate of the E187A mutant of Escherichia coli phosphofructokinase.
    Pham AS; Reinhart GD
    Biochemistry; 2001 Apr; 40(13):4150-8. PubMed ID: 11300796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible high hydrostatic pressure inactivation of phosphofructokinase from Escherichia coli.
    Deville-Bonne D; Else AJ
    Eur J Biochem; 1991 Sep; 200(3):747-50. PubMed ID: 1833191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MgATP and fructose 6-phosphate interactions with phosphofructokinase from Escherichia coli.
    Johnson JL; Reinhart GD
    Biochemistry; 1992 Nov; 31(46):11510-8. PubMed ID: 1445885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A proteolyzed derivative of Escherichia coli phosphofructokinase is no longer sensitive to allosteric effectors and still shows cooperativity in substrate binding.
    Le Bras G; Garel JR
    Biochemistry; 1982 Dec; 21(26):6656-60. PubMed ID: 6218818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and properties of the phosphofructokinase from Lactobacillus bulgaricus. A non-allosteric analog of the enzyme from Escherichia coli.
    Le Bras G; Deville-Bonne D; Garel JR
    Eur J Biochem; 1991 Jun; 198(3):683-7. PubMed ID: 1828763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphofructokinase: structure and control.
    Evans PR; Farrants GW; Hudson PJ
    Philos Trans R Soc Lond B Biol Sci; 1981 Jun; 293(1063):53-62. PubMed ID: 6115424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kinetics of effector binding to phosphofructokinase. The influence of effectors on the allosteric conformational transition.
    Roberts D; Kellett GL
    Biochem J; 1980 Sep; 189(3):569-79. PubMed ID: 6260084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of a two-state model to describe the influence of phospho(enol)pyruvate on phosphofructokinase from Escherichia coli.
    Johnson JL; Reinhart GD
    Biochemistry; 1997 Oct; 36(42):12814-22. PubMed ID: 9335538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of MgADP on phosphofructokinase from Escherichia coli. Elucidation of coupling interactions with both substrates.
    Johnson JL; Reinhart GD
    Biochemistry; 1994 Mar; 33(9):2635-43. PubMed ID: 8117726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.